Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07223619 · ClinicalTrials.gov registry record · NA

PILOT Phase: BPD Study

A NA study of Borderline Personality Disorder, sponsored by University of California, Los Angeles.

Active
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT07223619 is a NA study of Borderline Personality Disorder that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 20 participants, below the 106-participant average among 16 other Borderline Personality Disorder trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07223619, a NA study of Borderline Personality Disorder, is active but no longer recruiting, sponsored by University of California, Los Angeles.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This pilot study aims to identify the area of the brain best suited for the treatment of Borderline Personality disorder (BPD). The study investigators will test whether repetitiveTranscranial Magnetic Stimulation (rTMS), a gentle non-invasive brain stimulation method, can improve regulation of emotions and impulsivity in individuals with BPD. This study will enroll up to 20 participants. Participant will be consented for the study remotely via a secure internet platform called Zoom. Participants will undergo 1 Magnetic Resonance Imaging or MRI scan and up to 3 brain stimulation of transcranial magnetic stimulation or TMS sessions, and cognitive behavioral testing on a computer. Participants will complete 4 in-person visits over the course of up to 3 weeks.

Conditions Studied

Borderline Personality Disorder

Interventions

  • DEVICE Transcranial Magnetic Stimulation (TMS)

Study Locations (1)

California

  • Semel Institute/ UCLA TMS - Los Angeles

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-01-05
Est. Completion 2027-12-31
Phase NA

Sponsor

University of California, Los Angeles

897 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07223619

The ClinicalTrials.gov registry entry for NCT07223619 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 106-participant average among 16 other Borderline Personality Disorder trials with a reported enrollment target (81% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Borderline Personality Disorder appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Magnetic Stimulation (TMS) is the first listed.

NCT07223619 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07223619 about?

NCT07223619 is a clinical study titled "PILOT Phase: BPD Study". This pilot study aims to identify the area of the brain best suited for the treatment of Borderline Personality disorder (BPD). The study investigators will test whether repetitiveTranscranial Magnetic Stimulation (rTMS), a gentle non-invasive brain stimulation method, can improve regulation of emot...

What is the current status of trial NCT07223619?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-01-05. Estimated completion is 2027-12-31.

What conditions does trial NCT07223619 study?

This clinical trial studies the following conditions: Borderline Personality Disorder.

What interventions are being tested in trial NCT07223619?

The interventions under investigation include: Transcranial Magnetic Stimulation (TMS) (DEVICE).

Who is sponsoring clinical trial NCT07223619?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07223619 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Borderline Personality Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Borderline Personality Disorder

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.